Health Report Equatorial Guinea: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Report Equatorial Guinea.

Press releases published on August 28, 2026

10 hours ago

Minerva Neurosciences to Participate in Two Upcoming Investor Conferences

Indeterminate GlobeNewswire

10 hours ago

ENvue Medical, Inc. Announces 1-for-12 Reverse Stock Split

Indeterminate GlobeNewswire

10 hours ago

Advocates to hold nationwide Day of Action for federal action to stop two-tier, American-style health care

Indeterminate GlobeNewswire

10 hours ago

Micron Biomedical Honored with Georgia Life Sciences' Prestigious Phoenix Award for Transformative Research

Indeterminate GlobeNewswire

10 hours ago

Mobia Medical Announces Addition of Paired VNS to Updated AHA Stroke Guidelines

Indeterminate GlobeNewswire

11 hours ago

XORTX Announces Termination and Postponement of Investor Relations Program

Indeterminate GlobeNewswire

11 hours ago

Avricore Grants Options

Indeterminate GlobeNewswire

12 hours ago

Teva Announces Proposed Acquisition of a Novel Neuroscience Product Reinforcing Disciplined Business Development Approach Under Pivot to Growth Strategy 

Indeterminate GlobeNewswire

12 hours ago

Quoin Pharmaceuticals Reports Positive Interim Data from Ongoing Phase 2/3 Study of QRX003 in Netherton Syndrome

Indeterminate GlobeNewswire

12 hours ago

Immuron Reports FY26 Preliminary Results

Indeterminate GlobeNewswire

12 hours ago

BioXcel Therapeutics Enters Into Asset Sale Agreement with Teva Pharmaceuticals

Indeterminate GlobeNewswire

12 hours ago

Quoin Pharmaceuticals Announces Private Placement Financing of Up to $50.0 Million

Indeterminate GlobeNewswire

12 hours ago

Cytokinetics Announces Positive Results from ACACIA-HCM Presented in Hot Line Session at the European Society of Cardiology (ESC) Congress 2026 and Published in The New England Journal of Medicine

Indeterminate GlobeNewswire

13 hours ago

CDT Validates Enhanced Solid-Form Properties Within Its IP Portfolio

Indeterminate GlobeNewswire

15 hours ago

Chiesi Global Rare Diseases Demonstrates Its Ongoing Commitment to the Rare Disease Community at the Society of Inborn Errors of Metabolism (SSIEM) 2026 Annual Symposium

Indeterminate GlobeNewswire

15 hours ago

Chiesi Global Rare Diseases Demonstrates Its Ongoing Commitment to the Rare Disease Community at the Society of Inborn Errors of Metabolism (SSIEM) 2026 Annual Symposium

Indeterminate GlobeNewswire

15 hours ago

Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half

Indeterminate GlobeNewswire

16 hours ago

OSE Immunotherapeutics organisera un webcast dédié à lusvertikimab avec des leaders d’opinion le 2 septembre 2026

Indeterminate GlobeNewswire

16 hours ago

OSE Immunotherapeutics to host a KOL webcast dedicated to lusvertikimab on September 2, 2026

Indeterminate GlobeNewswire

Aug. 28, 2026

HUTCHMED Announces NMPA Approval for ATLED® (Fanregratinib) for the Treatment of Patients with FGFR2-Fusion/Rearrangement Intrahepatic Cholangiocarcinoma

Indeterminate GlobeNewswire